Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

RNA Inhibition Highlights Cyclin D1 as a Potential Therapeutic Target for Mantle Cell Lymphoma

  • Shiri Weinstein,

    Affiliations Laboratory of NanoMedicine, Department of Cell Research and Immunology, George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv, Israel, Center for Nanoscience and Nanotechnology, Tel Aviv University, Tel Aviv, Israel

  • Rafi Emmanuel,

    Affiliations Laboratory of NanoMedicine, Department of Cell Research and Immunology, George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv, Israel, Center for Nanoscience and Nanotechnology, Tel Aviv University, Tel Aviv, Israel

  • Ashley M. Jacobi,

    Affiliation Integrated DNA Technologies, Inc., Coralville, Iowa, United States of America

  • Avigdor Abraham,

    Affiliation Division of Hematology, Chaim Sheba Medical Center, Tel Hashomer, Israel

  • Mark A. Behlke,

    Affiliation Integrated DNA Technologies, Inc., Coralville, Iowa, United States of America

  • Andrew G. Sprague,

    Affiliation Alnylam Pharmaceuticals, Cambridge, Massachusetts, United States of America

  • Tatiana I. Novobrantseva,

    Affiliation Alnylam Pharmaceuticals, Cambridge, Massachusetts, United States of America

  • Arnon Nagler,

    Affiliation Division of Hematology, Chaim Sheba Medical Center, Tel Hashomer, Israel

  • Dan Peer

    peer@tauex.tau.ac.il

    Affiliations Laboratory of NanoMedicine, Department of Cell Research and Immunology, George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv, Israel, Center for Nanoscience and Nanotechnology, Tel Aviv University, Tel Aviv, Israel

Viewed

Cited

Saved

Discussed

Powered by Altmetric
Questions or concerns about usage data? Please let us know.